We are live on
!
Find out more
SCA
Summit Creek Advisors Portfolio holdings
AUM
$294M
1-Year Est. Return
19.1%
This Fund
S&P 500
This Quarter
Est. Return
-0.46%
1 Year Est. Return
+19.1%
3 Year Est. Return
+68.83%
5 Year Est. Return
+84.12%
10 Year Est. Return
+624.17%
AUM
$585M
AUM Growth
-$25.8M
(-4.2%)
Cap. Flow
-$13.2M
Cap. Flow
% of AUM
-2.25%
Top 10 Holdings %
Top 10 Hldgs %
31.57%
Holding
55
New
6
Increased
17
Reduced
29
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CYNO
Cynosure, Inc. Class A
CYNO
|
+$13.1M |
| 2 |
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
|
+$6.96M |
| 3 |
BEAT
BioTelemetry, Inc.
BEAT
|
+$4.52M |
| 4 |
HSKA
Heska Corp
HSKA
|
+$3.86M |
| 5 |
Tyler Technologies
TYL
|
+$3.39M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ligand Pharmaceuticals
LGND
|
+$8.88M |
| 2 |
BWLD
Buffalo Wild Wings, Inc.
BWLD
|
+$5.95M |
| 3 |
Duluth Holdings
DLTH
|
+$5.68M |
| 4 |
Gentherm
THRM
|
+$5.49M |
| 5 |
ELLI
Ellie Mae Inc
ELLI
|
+$5.48M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.55% |
| 2 | Healthcare | 25.45% |
| 3 | Consumer Discretionary | 17.6% |
| 4 | Industrials | 15.29% |
| 5 | Financials | 4.75% |
Similar funds
DMBA
ECM
CA
PPC
SM
FPM
DIGDR
DP
Summit Creek Advisors's Q4 2016 Portfolio in Review
As of Q4 2016, Summit Creek Advisors held 55 positions worth $585M, down 4.2% from $610M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Summit Creek Advisors's Q4 2016 filing shows 6 new, 17 increased, 29 reduced and 3 closed positions. Its largest new stake was Cynosure, Inc. Class A: 286,445 shares worth $13.1M. The largest sale was Ligand Pharmaceuticals, an estimated $8.88M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Summit Creek Advisors's largest Q4 2016 buy was Cynosure, Inc. Class A: 286,445 shares worth $13.1M.
- Summit Creek Advisors added most to Heska Corp in Q4 2016, an estimated $3.86M increase.
- Summit Creek Advisors's biggest Q4 2016 reduction was Ligand Pharmaceuticals, cutting an estimated $8.88M.
- Summit Creek Advisors fully exited Buffalo Wild Wings, Inc. in Q4 2016, selling an estimated $5.95M.
- Summit Creek Advisors's ten largest holdings make up 32% of its $585M portfolio in Q4 2016.
- Summit Creek Advisors opened 6 new positions and closed 3 in Q4 2016.
- Summit Creek Advisors's portfolio value fell 4.2% quarter-over-quarter to $585M.
Based on Summit Creek Advisors's 13F filing for Q4 2016, filed 20 Jan 2017.